Anavex updates on Alzheimer’s drug Phase I trial
The company’s decision follows the approval from a Safety Review Committee which has evaluated the safety data from the first group of healthy subjects. The clinical trial protocol
miRecule has signed a research collaboration with EM subsidiary Rio Biofarma Brasil (RBBL) to co-develop peptide-mediated delivery technologies aimed at improving targeted ribonucleic acid (RNA) therapeutics delivery to tissues beyond the liver and muscles in a range of disease areas.
Nitrofurantoin oral suspension is an anti-bacterial medication indicated for the treatment of urinary tract infection. Amneal’s Nitrofurantoin oral suspension is generic version and therapeutically equivalent alternative to Furadantin